Atrium Therapeutics (RNA) EBITDA (2025 - 2026)
Atrium Therapeutics (RNA) EBITDA from Mar 31, 2025 to Mar 31, 2026. The TTM Atrium Therapeutics (RNA) EBITDA is -$17M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Quarterly EBITDA
Atrium Therapeutics (RNA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +131.49% |
Annual EBITDA change of Atrium Therapeutics (RNA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$17M | +131.49% |
| 2025 | -$7.40M | N/A |